Syria pharmaceutical market entry

A practical route into Syria’s pharmaceutical market.

We help international pharmaceutical companies understand the opportunity, identify qualified local partners and execute market entry — while helping Syrian manufacturers access credible international products, development and technology-transfer capability.

Syria focusedIndia, China & Europe partner networksEvidence-ledBuilt for execution

Why Syria, why now

A re-emerging market with an established pharmaceutical base.

Syria is not a blank market. It has a long-standing manufacturing sector, technical talent and companies seeking reliable supply, differentiated products and international know-how.

The opportunity comes with real complexity: regulatory requirements, banking and compliance, market data gaps and the need to qualify counterparties carefully. We help international partners approach Syria with a grounded market view and a controlled entry plan — not assumptions.

01

Industrial foundation

An existing pharmaceutical manufacturing community and local technical capability.

02

Capability gaps

Demand for reliable APIs, specialised products, dossiers and reproducible technology transfer.

03

Reconnection

Renewed interest in international partnerships as the market enters a new phase.

04

First-mover timing

Room for credible partners who enter carefully, learn early and build trusted local relationships.

Two markets, one accountable bridge

Connect opportunity to the capability required to deliver it.

We work from both directions: international companies entering Syria and Syrian manufacturers seeking the right overseas partner.

01

Market entry for international partners

Understand the Syrian opportunity, identify credible manufacturers and customers, and shape a practical route to market.

Market intelligence · Partner search · Commercial representation

02

International capability for Syrian manufacturers

Find and qualify API, formulation, dossier and technology-transfer partners with evidence that fits the local need.

Product screening · Partner qualification · Comparable RFQs

03

Execution across both sides

Coordinate scope, technical communication, regulatory support, transfer readiness and commercial follow-through.

Project governance · Technology transfer · Supply continuity

A controlled entry model

Make the introduction useful — then make the project work.

Our value is not a list of names. It is the local context, partner qualification, structured scope and project governance that turn an introduction into a viable commercial relationship.

01

Validate the opportunity

We test the customer need, product fit and likely route before asking either side to commit resources.

02

Qualify the counterparties

Facilities, regulatory history, development ownership and transfer evidence matter more than a catalogue or low quote.

03

Govern the execution

Defined outputs, decision gates, data rights and clear communication keep the partnership commercially and technically aligned.

For companies in India, China and Europe

Explore Syria with a local commercial and execution partner.

If you own a strong API, finished product, dossier or development capability, we can help assess its relevance, identify suitable Syrian counterparties and coordinate the route from first discussion to a defined project.

Explore the opportunity

A practical first conversation

  1. 01 Your products, technical capability and ownership
  2. 02 The Syrian customer or market need it may address
  3. 03 Registration, transfer and commercial route
  4. 04 A focused next step with clear evidence required

Syria starts with local understanding

Have a product, capability or market opportunity to assess?

hello@sanadpharma.com

Independent pharmaceutical consultancy, market-entry and commercial support.